Mithra Pharmaceuticals (CHIX:MITRAB) Research & Development

: €68.91 Mil (TTM As of Jun. 2023)

View and export this data going back to 2015. Start your Free Trial

Research & Development is the aggregate amount of research and development expenses during the year. Mithra Pharmaceuticals's Research & Development for the six months ended in Jun. 2023 was €32.39 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Jun. 2023 was €68.91 Mil.

Mithra Pharmaceuticals Research & Development Historical Data

The historical data trend for Mithra Pharmaceuticals's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mithra Pharmaceuticals Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Research & Development

35.71

57.07

78.46

85.24

64.04

Mithra Pharmaceuticals Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
Research & Development																36.76	48.49	27.52	36.52	32.39

Mithra Pharmaceuticals Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €68.91 Mil.

Mithra Pharmaceuticals (CHIX:MITRAb) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Mithra Pharmaceuticals Research & Development Related Terms

Thank you for viewing the detailed overview of Mithra Pharmaceuticals's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Mithra Pharmaceuticals (CHIX:MITRAB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mithra Pharmaceuticals SA (CHIX:MITRAb) » Definitions » Research & Development

Comparable Companies

Traded in Other Exchanges

0R91:UK 1TM:Germany MITRA:Belgium

Address

Rue Saint-Georges 5, Liege, BEL, 4000

Website

https://www.mithra.com

Mithra Pharmaceuticals SA develops products for women's health with a particular focus on fertility, contraception, and menopause. It operates in three segments: Product Sales, Out-licensing, and Other. The company also develops and markets complex therapeutic solutions and offers partners a complete spectrum of research, development, and specialist manufacturing at its Mithra CDMO. Its geographical segments are Belgium, Europe and Outside Europe.

Mithra Pharmaceuticals (CHIX:MITRAB) Headlines

No Headlines